Cargando…

Optical coherence tomography evaluation of pulmonary arterial vasculopathy in Systemic Sclerosis

Our current understanding of the pathophysiology of pulmonary vascular disease is incomplete, since information about alterations of the pulmonary vasculature in pulmonary arterial hypertension (PAH) is primarily provided by autopsy or tissue specimens. The aim of this study was to compare the dista...

Descripción completa

Detalles Bibliográficos
Autores principales: Schwaiger, Johannes P., Loder, Christopher D., Dobarro, David, Kaier, Thomas, Reddecliffe, Sally, Schreiber, Benjamin E., Handler, Clive, Denton, Christopher P., Coghlan, John G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5324107/
https://www.ncbi.nlm.nih.gov/pubmed/28233825
http://dx.doi.org/10.1038/srep43304
_version_ 1782510155933417472
author Schwaiger, Johannes P.
Loder, Christopher D.
Dobarro, David
Kaier, Thomas
Reddecliffe, Sally
Schreiber, Benjamin E.
Handler, Clive
Denton, Christopher P.
Coghlan, John G.
author_facet Schwaiger, Johannes P.
Loder, Christopher D.
Dobarro, David
Kaier, Thomas
Reddecliffe, Sally
Schreiber, Benjamin E.
Handler, Clive
Denton, Christopher P.
Coghlan, John G.
author_sort Schwaiger, Johannes P.
collection PubMed
description Our current understanding of the pathophysiology of pulmonary vascular disease is incomplete, since information about alterations of the pulmonary vasculature in pulmonary arterial hypertension (PAH) is primarily provided by autopsy or tissue specimens. The aim of this study was to compare the distal pulmonary vasculature of <2 mm in diameter in Systemic Sclerosis (SSc) patients with (n = 17) and without (n = 5) associated PAH using Optical Coherence Tomography during Right Heart catheterization. SSc-PAH patients showed significant thickening of Intima Media Thickening Area compared to patients without PAH (27 +/− 5.8% vs. 21 +/− 1.4%, p = 0.024). A good haemodynamic response to previous targeted PAH treatment was associated with a significantly greater number of small pulmonary artery side branches <300 μm per cm vessel (3.8 +/− 1.1 vs. 1.8 +/− 1.1; p = 0.010) and not associated with Intima Media thickening Area (26 +/− 5.4% vs. 28 +/− 6.7%; p = 0.6). Unexpected evidence of pulmonary artery thrombus formation was found in 19% of SSc-PAH patients. This is the first in-vivo study demonstrating a direct link between a structural abnormality of pulmonary arteries and a response to targeted treatment in PAH. Intravascular imaging may identify subgroups that may benefit from anticoagulation.
format Online
Article
Text
id pubmed-5324107
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Nature Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-53241072017-03-01 Optical coherence tomography evaluation of pulmonary arterial vasculopathy in Systemic Sclerosis Schwaiger, Johannes P. Loder, Christopher D. Dobarro, David Kaier, Thomas Reddecliffe, Sally Schreiber, Benjamin E. Handler, Clive Denton, Christopher P. Coghlan, John G. Sci Rep Article Our current understanding of the pathophysiology of pulmonary vascular disease is incomplete, since information about alterations of the pulmonary vasculature in pulmonary arterial hypertension (PAH) is primarily provided by autopsy or tissue specimens. The aim of this study was to compare the distal pulmonary vasculature of <2 mm in diameter in Systemic Sclerosis (SSc) patients with (n = 17) and without (n = 5) associated PAH using Optical Coherence Tomography during Right Heart catheterization. SSc-PAH patients showed significant thickening of Intima Media Thickening Area compared to patients without PAH (27 +/− 5.8% vs. 21 +/− 1.4%, p = 0.024). A good haemodynamic response to previous targeted PAH treatment was associated with a significantly greater number of small pulmonary artery side branches <300 μm per cm vessel (3.8 +/− 1.1 vs. 1.8 +/− 1.1; p = 0.010) and not associated with Intima Media thickening Area (26 +/− 5.4% vs. 28 +/− 6.7%; p = 0.6). Unexpected evidence of pulmonary artery thrombus formation was found in 19% of SSc-PAH patients. This is the first in-vivo study demonstrating a direct link between a structural abnormality of pulmonary arteries and a response to targeted treatment in PAH. Intravascular imaging may identify subgroups that may benefit from anticoagulation. Nature Publishing Group 2017-02-24 /pmc/articles/PMC5324107/ /pubmed/28233825 http://dx.doi.org/10.1038/srep43304 Text en Copyright © 2017, The Author(s) http://creativecommons.org/licenses/by/4.0/ This work is licensed under a Creative Commons Attribution 4.0 International License. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in the credit line; if the material is not included under the Creative Commons license, users will need to obtain permission from the license holder to reproduce the material. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/
spellingShingle Article
Schwaiger, Johannes P.
Loder, Christopher D.
Dobarro, David
Kaier, Thomas
Reddecliffe, Sally
Schreiber, Benjamin E.
Handler, Clive
Denton, Christopher P.
Coghlan, John G.
Optical coherence tomography evaluation of pulmonary arterial vasculopathy in Systemic Sclerosis
title Optical coherence tomography evaluation of pulmonary arterial vasculopathy in Systemic Sclerosis
title_full Optical coherence tomography evaluation of pulmonary arterial vasculopathy in Systemic Sclerosis
title_fullStr Optical coherence tomography evaluation of pulmonary arterial vasculopathy in Systemic Sclerosis
title_full_unstemmed Optical coherence tomography evaluation of pulmonary arterial vasculopathy in Systemic Sclerosis
title_short Optical coherence tomography evaluation of pulmonary arterial vasculopathy in Systemic Sclerosis
title_sort optical coherence tomography evaluation of pulmonary arterial vasculopathy in systemic sclerosis
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5324107/
https://www.ncbi.nlm.nih.gov/pubmed/28233825
http://dx.doi.org/10.1038/srep43304
work_keys_str_mv AT schwaigerjohannesp opticalcoherencetomographyevaluationofpulmonaryarterialvasculopathyinsystemicsclerosis
AT loderchristopherd opticalcoherencetomographyevaluationofpulmonaryarterialvasculopathyinsystemicsclerosis
AT dobarrodavid opticalcoherencetomographyevaluationofpulmonaryarterialvasculopathyinsystemicsclerosis
AT kaierthomas opticalcoherencetomographyevaluationofpulmonaryarterialvasculopathyinsystemicsclerosis
AT reddecliffesally opticalcoherencetomographyevaluationofpulmonaryarterialvasculopathyinsystemicsclerosis
AT schreiberbenjamine opticalcoherencetomographyevaluationofpulmonaryarterialvasculopathyinsystemicsclerosis
AT handlerclive opticalcoherencetomographyevaluationofpulmonaryarterialvasculopathyinsystemicsclerosis
AT dentonchristopherp opticalcoherencetomographyevaluationofpulmonaryarterialvasculopathyinsystemicsclerosis
AT coghlanjohng opticalcoherencetomographyevaluationofpulmonaryarterialvasculopathyinsystemicsclerosis